The "Myopia Management White Paper (2022)" addresses the rising prevalence of myopia among children and adolescents in China, now at 52.7%. It emphasizes the need for effective management strategies and updates previous guidelines from 2019. Key sections include myopia staging for tailored management, comprehensive monitoring of risk factors and eye health, advancements in optical and pharmacological interventions, and the importance of combined approaches. It also highlights the need for special attention to preschool children and those with high myopia. The paper serves as a comprehensive, evidence-based guide for clinicians to address the myopia epidemic in youth.